Manhattan Bridge Capital (LOAN) Stock Price, News & Analysis

Manhattan Bridge Capital's stock was trading at $4.97 at the beginning of 2024. Since then, LOAN shares have increased by 2.2% and is now trading at $5.08.
View the best growth stocks for 2024 here.

Manhattan Bridge Capital saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 28,800 shares, an increase of 35.2% from the March 15th total of 21,300 shares. Based on an average daily trading volume, of 21,000 shares, the short-interest ratio is presently 1.4 days. Currently, 0.3% of the company's stock are sold short.
View Manhattan Bridge Capital's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, April 22nd 2024.
View our LOAN earnings forecast.

Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) posted its earnings results on Friday, March, 11th. The credit services provider reported $0.09 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.10 by $0.01. Manhattan Bridge Capital had a trailing twelve-month return on equity of 12.77% and a net margin of 55.91%.

Manhattan Bridge Capital announced a quarterly dividend on Wednesday, March 13th. Stockholders of record on Wednesday, July 10th will be given a dividend of $0.115 per share on Monday, July 15th. This represents a $0.46 annualized dividend and a yield of 9.06%. The ex-dividend date is Wednesday, July 10th.
Read our dividend analysis for LOAN.

Manhattan Bridge Capital (NASDAQ:LOAN) pays an annual dividend of $0.46 per share and currently has a dividend yield of 9.13%. LOAN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 95.83%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for LOAN.

Based on aggregate information from My MarketBeat watchlists, some companies that other Manhattan Bridge Capital investors own include Allena Pharmaceuticals (ALNA), Energy Transfer (ET), AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), B&G Foods (BGS), Enterprise Products Partners (EPD), Global Medical REIT (GMRE), Kimco Realty (KIM), Mylan (MYL) and Rigel Pharmaceuticals (RIGL).

Manhattan Bridge Capital's stock is owned by a number of retail and institutional investors. Top institutional investors include Melia Wealth LLC (0.54%), Abacus Wealth Partners LLC (0.49%) and Wealthcare Advisory Partners LLC (0.40%). Insiders that own company stock include Assaf Ran and Michael Jackson.
View institutional ownership trends.

Shares of LOAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.